Avamed Synergy
Avamed Synergy is an innovative Spanish company focused on advancing digital surgery through its flagship product, Fluxus. Fluxus is an AI-assisted clinical environment designed to predict tumor evolution and assist in surgical planning. It aims to change the paradigm in predictive oncology by providing a systematic method to forecast the future state of individual tumors. The platform uses proprietary AI algorithms to model tumor-host interfaces with multi-scale data and uncertainty quantification, enabling a deeper understanding of tumor behavior. This technology supports personalized medicine, improves surgical precision, reduces errors, and ultimately enhances patient outcomes while also reducing healthcare costs for society. Avamed Synergy has secured significant funding and recognition, including IVACE+i project approvals and the PYME Innovadora seal.
Avamed Synergy
Avamed Synergy is an innovative Spanish company focused on advancing digital surgery through its flagship product, Fluxus. Fluxus is an AI-assisted clinical environment designed to predict tumor evolution and assist in surgical planning. It aims to change the paradigm in predictive oncology by providing a systematic method to forecast the future state of individual tumors. The platform uses proprietary AI algorithms to model tumor-host interfaces with multi-scale data and uncertainty quantification, enabling a deeper understanding of tumor behavior. This technology supports personalized medicine, improves surgical precision, reduces errors, and ultimately enhances patient outcomes while also reducing healthcare costs for society. Avamed Synergy has secured significant funding and recognition, including IVACE+i project approvals and the PYME Innovadora seal.